Muscle mass loss in breast cancer patients of reproductive age (≤ 45 years) undergoing neoadjuvant chemotherapy.
Federica RossiMatteo LambertiniNicole BrunettiSara De GiorgisMaria Grazia RazetiMassimo CalabreseAlberto Stefano TagliaficoPublished in: La Radiologia medica (2022)
PMA variation in BC young patients, directly estimated on breast MRI, could be a potential tool to monitor body composition during NAC with potential implications in improving outcome.
Keyphrases
- body composition
- neoadjuvant chemotherapy
- end stage renal disease
- ejection fraction
- resistance training
- locally advanced
- newly diagnosed
- bone mineral density
- lymph node
- magnetic resonance imaging
- transcription factor
- prognostic factors
- sentinel lymph node
- contrast enhanced
- human health
- risk assessment
- early stage
- postmenopausal women
- climate change